CareCloud Inc. Common Stock (CCLD)
Fast GrowerFairStock Score: 51/100 — MIXED
Key Financials
| Current Price | $2.11 |
| Market Cap | $129M |
| P/E Ratio | 16.23 |
| ROE | 17.37% |
| Dividend Yield | —% |
| Sector | Healthcare |
Strengths
- Generates $18 million in annual free cash flow (14.1% yield on market cap)
- Solid return on equity of 19.8% above cost of capital
- Conservative balance sheet with debt-to-equity of just 0.07, providing financial flexibility
- Revenue growth of 21.9% demonstrates strong top-line momentum
Concerns
- Trades significantly above Graham Number ($2) with negative 72% margin of safety—limited downside protection
AI Analysis
CareCloud Inc. Common Stock is a micro-cap healthcare company valued at $129 million. The business generates $120 million in annual revenue with a 1.3% net margin and $18 million in free cash flow. From a quality standpoint, CareCloud shows Altman Z-Score of 2.4 in the grey zone and adequate 20% ROE. On valuation, the stock is trading at a premium 30.1x earnings, with trades above its Graham Number with a negative 72% margin. Growth dynamics show revenue growing at 21.9% and profit growth of -12.4%. Our composite FairStock Score of 51/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
CareCloud's 22% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. With $18 million in annual free cash flow (14.1% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
At 30x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer